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Abstract  
 
Objective: The study aimed to determine if an educational intervention will improve COPD 
exacerbations in African American population after a 6-week self-management program that 
includes the proper use of an inhaler. 
Methods: Ten patients were recruited in a primary care setting with the assistance of the 
providers. All patients had to complete a pretest and a posttest to assess their knowledge of 
inhaler technique, their willingness to engage in self-efficacy disease management, their 
symptoms improvement and treatment adherence. The Inhaler Device Assessment Tool, the Self-
Efficacy for Managing Chronic Disease 6-Item Scale, the CAT test, and the TAI test were the 
tools used for the project. 
Results: In the recruited population, 70 % were females and 30% were males.  In the pretest and 
posttest of the inhaler technique, there is an improvement difference of 1.5 %, with a mean of 3.1 
% in the pretest, and 4.6 % in the posttest. The CAT test has a mean of 17.9 with a standard 
deviation (SD) of 7.25 in the pretest, and a mean of 9.9 and a SD of 6.21. The CAT test has 
difference of 8. Self-efficacy management shows a difference of 3.4 with a mean value of 53 and 
56.4 in the pretest and posttest respectively. Inhaler adherence has a mean value of 46.4 in the 
pretest and 49.3 in the posttest with a difference of 2.9 in inhaler adherence improvement. 
Conclusion: The study reveals that teaching the proper use of an inhaler can improve COPD 
symptoms and decrease the frequency of COPD exacerbations in African American population 
after a 6-week self-management program, but further studies are needed to validate the findings. 
Keywords: African American, chronic obstructive pulmonary disease, COPD exacerbation, 
inhalation technique, adherence, self-management.  
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Introduction 
COPD exacerbation constitutes one of the leading causes of hospitalization or emergency 
department visit among COPD patients older than 40-year-old (Sogaard et al., 2016). People with 
COPD may have four episodes of exacerbation annually (Criner & Han, 2018). According to 
Sogaard et al. (2016), over 10% of COPD exacerbation attacks necessitate hospital admission. 
COPD exacerbation is described as an acute escalation of dyspnea, cough and purulent sputum, 
not responding to routine treatment (Criner & Han, 2018). Researchers have shown that COPD 
exacerbation is due to respiratory infections in 50-75% of the cases (Sogaard et al., 2016). 
Patients affected with chronic obstructive pulmonary disease (COPD) may face numerous 
challenges, such as poor life quality and frequent emergency department visits, due to COPD 
exacerbation (George & George, 2012). COPD exacerbations are linked with many causes of 
sickness and death (Bourbeau & Echevarria, 2020). COPD management requires a 
multidisciplinary team to meet patients’ needs (Bourbeau & Echevarria, 2020).  
In addition to the disease burden, COPD is linked with significant financial expenses. 
(Kirsch et al., 2019). One of the main causes of COPD increased expenses is hospital admission 
and readmission (Derdak, 2017). Patel et al. (2018) explain COPD direct health care expenses 
were estimated to more than half ($30 billion) of the nationwide anticipated expenditure for 
COPD in 2010 (estimation: $49.9 billion). Indirect COPD costs related to co-morbidity and lost 
productivity accounted for $8 billion of the predicted total expenses in 2010 (Patel et al, 2018).  
The trend of high expenses for COPD is seen globally. Kirsch et al. (2019) reveal that the total 
direct expenses for COPD are guesstimated to be about 3% (€38.6 billion) of the overall health 
care financial plan in the European Union. Furthermore, Siddharthan et al. (2018) identify COPD 
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exacerbations as one of the main causes of morbidity and direct healthcare expenditures in 
developed countries.  
Background 
As George (2018) explains, patients with low social interaction and reduced physical 
activity undergo depression, anxiety and loss of independence and self-reliance, which may 
conduct to a damaging impact on the individuals and their family. COPD is a condition that can 
create severe physical and mental limitations and deteriorate life-quality of affected individuals 
(Cannon, Sriam, Wee-Chung Liew & Jing Sun, 2018). Patients affected with COPD experience 
severe chronic illness complications which negatively impact health-related quality of life 
(Bringsvor, 2019). The breathing difficulty associated with COPD leads to frailty that impacts not 
only the patients’ daily activities but also their social contact and productivity. Likewise, Criner 
and Han (2018) argue physical activities and sleep quality are considerably decreased in 70% and 
50% of patients with COPD, respectively.  
COPD represents an enormous burden on healthcare cost. As reported by Criner and Han 
(2018), COPD care expenditures were guesstimated about $49 billion in direct and indirect health 
care cost in 2010. The numerous comorbidities associated with COPD explain the indirect costs 
(Criner & Han, 2018). Various evidences have revealed that 9% of people with COPD have an 
increased probability to be unemployed, and 4% of them have a high possibility to fetch for 
financial assistance through Social Security Disability Insurance (Criner & Han, 2018). Other 
factor that can be taking into account is patient adherence to treatment. The multiple medications, 
inhaler technique, nebulizer and oxygen use involved in COPD management make it difficult for 
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patients to adhere to treatment, which may be responsible for an increased risk of COPD-related 
death (George, 2018).  
A clear understanding of the pathogenesis and management of COPD exacerbation may 
assist healthcare clinicians to empower COPD patients with the basic knowledge to improve their 
overall health and reduce COPD-related hospitalization. This paper intends to conduct a literature 
review to explore and understand the outcome of implementing a COPD self-management 
program to assist African Americans with COPD improving their health status and reducing 
hospitalization rates. 
Search Strategies 
CINAHL, EBSCO, and PUBMED are the main databases consulted to conduct the 
literature review. Search strategies using Boolean operators, keywords, phrases, and abbreviations, 
were used to scrutinize the databanks. The words utilized to search the database were: “(COPD or 
chronic obstructive pulmonary disease or chronic obstructive airway disease or chronic obstructive 
lung disease)”, “(self-management or self-care or self-regulation or self-monitoring)”, “ inhaler 
technique or inhaler method or inhaler management”, and “(black or African American or African 
American or color or minority)”.  
The search was limited to academic journals published between January 2000 and April 
2020. In CINHAL database, the first search retrieved 649 articles. When using Booleans and 
truncation, the number of articles decreased to 15 articles about COPD, self-management, 
inhalation technique, and two articles related to African Americans. In PubMed, the initial search 
showed 45 articles, and the search reduced to 7 articles about COPD, self-management, 
inhalation technique, and three articles related to African Americans. A total of 22 articles was 
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chosen, and five of them will be fully scrutinized. The remaining of the articles along with other 
scholarly reviews will be used as supporting evidence for the project.  
Literature Review  
COPD Self-Management on Health-Related Quality of Life and Hospitalization 
COPD is a usual and permanent lung illness, which is responsible for considerable 
infirmity, lessens quality of life and augments probability of premature decease (Cannon, Sriam, 
Wee-Chung Liew & Jing Sun, 2018). Hospital stay and emergency department (E) visits are very 
frequent among COPD patients.  A 2017 Cochrane Airways Group study highlights the effect of 
COPD self-management on health-related quality of life and hospitalization by paralleling self-
care approaches that encompass strategies for acute exacerbations of COPD (AECOPD) vs routine 
care (Lenferink et al., 2017). The search criteria include studies with randomized controlled trial 
from 1995 to 2016 conducted for COPD patients. Inclusion criteria for self-management plan 
comprise a scripted strategy for AECOPD and a repetitive process between participants and 
clinicians (Lenferink et al., 2017). Patients who participated in a pulmonary rehabilitation program 
or an exercise training realized at a hospital or rehabilitation center were excluded. Two 
independent authors gathered and appraised the data. A third author was sometimes involved to 
solve conflict or to reach agreement. In some instances, to gather further information and to obtain 
missing data, researchers had communicated to the study authors (Lenferink et al., 2017). Meta-
analysis model was used when suitable to search for study results. The systematic review 
encompasses 22 studies implicating 3,854 participants. Each research had a control group and was 
followed from 2 to 24 months (Lenferink et al., 2017). The primary search had generated 1811 
articles and abstracts, but only 22 articles met the inclusion criteria (Lenferink et al., 2017). The 
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five elements of the GRADE framework (Grades of Recommendation, Assessment, Development 
and Evaluation) were used to conduct the review. The quality of evidence for health-related quality 
of life (HRQoL) was qualified as high. In the study, health-related quality of life was appraised 
using the St. George's Respiratory Questionnaire (SGRQ). Causes of hospitalization, primary care 
visits, emergency department visits, and dyspnea symptoms were assessed by the Medical 
Research Council Questionnaire (MRCQ). 
Study Outcome  
The finding of the studies has shown that self-management program has shown 
improvement in HRQoL in COPD patients. The results also reveal that there is a significant 
decrease in COPD-related hospital admission for patients using self-care strategies for AECOPD 
as opposed to those receiving routine care. In addition, the study outcomes have open door for 
further studies incorporating patients’ adherence to COPD self-management interventions, COPD 
associated comorbidities and self-management interventions, and financial appraisal of the 
application of COPD self-management plans. Patients’ literacy constitutes an important obstacle 
to promote COPD self-management interventions. In the era of Internet and smart technologies, 
patients’ education may be accomplished through audio-visual media.  
COPD Impact in the African American Community 
Although extensive research studies cover the influence of COPD health-related quality of 
life (HRQL) and treatment adherence in the general population, very few studies have been 
conducted in the African American groups. It has been demonstrated that factors such as lung 
structure, exercise tolerance, comorbidities, depression and literacy level exert a significant impact 
on HRQL in COPD; however, limited studies have assessed racial influence on HRQL (Han et al., 
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2011). Researchers have pointed out that COPD constitutes a critical health concern for African 
Americans, and death rates related to COPD had augmented faster for African Americans than for 
white people between 1980 and 2000 (Mina et al., 2012). Likewise, COPD has been recognized 
as a responsible factor in weakening HRQL in African Americans aged 45 to 65 (Han et al., 2011).  
Considering factors such as “age, gender, FEV1 % predicted, pack-year smoking history, 
modified medical research council (MMRC) dyspnea scale, 6-min walk distance (6MWD), 
education, current smoking status, and exacerbation frequency”, Han et al. (2011) have conducted 
a study using the St. George Respiratory Questionnaire (SGRQ) and the adapted Medical Research 
Council Dyspnea (MMRC) scale to assess the association between HRQL and symptoms. The 
findings revealed no difference for African Americans and Caucasians with COPD without 
exacerbations; however, poorer HRQL was observed among African Americans who endure 
exacerbations, mainly those who were admitted for COPD exacerbations (Han et al., 2011). 
Sarrazin et al. (2009) indorse the outcome that African Americans are more likely to undergo 
severe episodes of exacerbations. They pointed out African American people hospitalized at 
Veterans Administration hospitals with COPD exacerbations were more prone to be admitted to 
the ICU and obtain automated ventilation (Sarrazin et al., 2009).  In a small racial comparison for 
COPD patients, Han et al. (2011) report African Americans present more dyspnea and lesser 
HRQL than Caucasians. The relationship between race and HRQL is very complicated, stated Han 
et al. (2011). Multiple factors may affect HRQL. It is worth mentioning racial inequalities, socio-
economic status and education are among the factors that can impact HRQL, which symbolize the 
social disparities noticed among African Americans (Han et al., 2011). 
Limitation and Strength  
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The study has some limitations and potential bias; for instance, subjects were enrolled 
through educational organizations, as such, the results of the study may have some types of 
tertiary-care hospital partiality (Han et al., 2011). The strength of the study is a large number of 
African Americans taking part in the survey (Han et al., 2011). Han et al. (2011) underscore that 
it is critical to creating strategies intended to enhance the prevention and management of COPD 
exacerbations in the African American people. 
Disease Management Program for COPD vs Usual Care for COPD 
The impact of COPD exacerbation on hospitalization rates is well-known. Rice et al. (2010) 
elucidate that aggravating symptoms of COPD are accountable for 726,000 hospitalizations and 
1.5 million emergency room (ER) encounters in the United State. Due to the burden effects of 
COPD on health care use, Rice et al. have conducted a randomized control trial study to establish 
the outcome of disease management for COPD on hospital admission rates and ER visits. 
The study has taken place in five Veterans Affairs (VA) hospitals. The study intended to 
compare the effect of disease management to usual care for COPD patients. The medical board 
has approved the study, and the patients have provided informed consents (Appendix E). The study 
encompasses a total of 743 individuals affected with COPD. At the first visit, there were 761 
patients, but 18 of them did not meet spirometry measures. The researchers randomly divided the 
patients into 2 different groups; 371 patients were in the routine care group, and the remaining 372 
were attributed to the disease management group.  
The intervention for disease management consists of 1- to 1.5-hour training session, an 
action plan for self-management of exacerbations, and once-a-month follow-up calls from a case 
manager. The study was a one-year trial. The main result was the combined number of 
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hospitalization and ED visits per patients over a year. The secondary results comprised 
hospitalizations and ED visits for all reasons, pulmonary medication use, death, and variation in 
Saint George's Respiratory Questionnaire. 
The training session consisted of COPD general knowledge, inhaler technique observation, 
medication reconciliation, recommendation regarding smoking cessation, and influenza and 
pneumococcal vaccination. Each participant obtained a personalized written action plan. The Saint 
George’s Respiratory Questionnaire was used to evaluate the respiratory symptoms in both groups. 
The evaluation of the primary outcome was done using a comparative estimation of the 
mean cumulative functions between disease management and usual care (Rice et al., 2010).  For 
the secondary outcome,  the researchers have applied a linear model with log link and negative 
binomial random to compete hospital admission rates and ED visits, and a general or simplified 
linear regression function to relate all-cause and site-adjusted mortality rates, total days of 
hospitalization, total days in the ICU, number of outpatient respiratory medication prescriptions, 
and variations in quality of life (Rice et al., 2010).The intervention group had a 41% reduction in 
the primary outcome. The study concluded a disease program can decrease hospitalization and ED 
visits due to COPD (Rice et al., 2010).  The findings support a simple but effective intervention 
for a COPD disease management strategy to lessen hospital admission and ED visits. 
Study Strengths and Limitations.  
The study has shown consistency of the results over time and with different subgroup 
studies (Rice et al., 2010). It is the largest research of disease management in COPD patients (Rice 
et al., 2010). Previous studies have shown mixed results. Rice et al. (2010) argue 
the study outcome was identical with the constructive results of those aforementioned 
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studies despite the significant dissimilarity in the intervention program. The study limitations rely 
on the fact that all patients in the study were men and have advanced diseases. It is not known if 
the results of the study will be similar for women or patients with non-advanced diseases. Further 
comparative studies are needed. 
Health Coaching and Self-Management Abilities in Severe COPD  
Primary care clinicians thrive to improve the quality of life of COPD patients. It is essential 
to have available tools or guidelines to fill this purpose.  Benzo and McEvoy (2019) have analyzed 
several randomized studies to elucidate the effect of health coaching conducted by a respiratory 
therapist or a nurse on self-management abilities. The researchers hypothesized health coaching 
can enhance self-management skills. Benzo and McEvoy (2019) explain health coaching is able 
to increase self-management abilities because it is founded in the principle of motivational 
interviewing, which is described as a concept tailored to the patient and structured in an interactive 
communication and a change of comportment.  
The study aims to parallel the outcome of health coaching provided by a respiratory 
therapist or a nurse with routine care self-management abilities. Self-management abilities (SMA) 
will be appraised by the Chronic Respiratory Disease Questionnaire mastery domain (Benzo & 
McEvoy, 2019). The domain comprises two concepts of SMA, which are self-efficacy to cope 
with COPD and COPD symptoms and to manage emotional stress due to COPD exacerbations 
(Benzo & McEvoy, 2019). The research comprises 215 patients who were admitted for an 
exacerbation of COPD. The patients were randomly distributed to the intervention or the control 
(Benzo & McEvoy, 2019). 
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The study design was constructed as a subsequent analysis of previous randomized trial 
studies that compared a health-coaching practice with routine care based on guideline for patients 
after hospital discharge for COPD exacerbations. Data was collected from several sites, such as 
“Mayo Clinic, Rochester, Minnesota, and Health Partners Regions Hospital, Minneapolis, 
Minnesota”. Assignment of patients was randomly done using an online computer-generated 
simple binomial randomization program into the 2 units (Benzo & McEvoy, 2019). Criteria of 
inclusion encompass hospitalizations due to COPD as a primary diagnosis and a probability to 
communicate with a coach by telephone (Benzo & McEvoy, 2019). A committee was responsible 
to oversee patient accrual, results, obstacles, and procedure observance. The authors compare 
changes noted at the start, at 6 months and at 12 months of the intervention between the two study 
branches applying “2-sample, 2-sided t tests with 5% type-1 error rates”. The sensitivity of the 
logistic models was evaluated by means of 10,000 bootstrapped samples. The researchers apply a 
SAS version 9.4 to compute the results.  
The authors conclude that health coaching is effective to reduce hospital readmission, 
enhances the quality of life, and shows a significant improvement of the Chronic Respiratory 
Disease Questionnaire mastery score (Benzo & McEvoy, 2019). The change noted in the Chronic 
Respiratory Disease Questionnaire mastery domain was clinically significant at six months but 
showed a trend at 12 months with no significant clinical difference. The study reveals health 
coaching by motivational interviewing empowers the subjects to take control of their health and 
increases coping strategy for the emotions related to COPD exacerbations.  
Study Strength and Limitation 
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One of the strengths of the study is that it can be replicated due to the fact health coaching 
is comprehensive and the Chronic Respiratory Disease Questionnaire mastery domain is easy to 
apply (Benzo & McEvoy, 2019). Prior randomized controlled studies on COPD self-management 
fail to determine a reduction in COPD exacerbation or hospitalization frequency, or they show an 
augmentation in death rate. Likewise, the study by Bischoch et al, using the same measure (The 
Chronic Respiratory Disease Questionnaire) could not demonstrate a change in hospitalization 
rates. The authors acknowledge the results of the study need to be replicated to ascertain the role 
of health coaching in COPD management since the types of communication (motivational 
interviewing) between the coach and the patient might be the reason of that outcome. The absence 
of replication of the study results constitutes a limitation of the study (Benzo & McEvoy, 2019). 
Another limitation of the study is the fact the study results did not show a clinical significance in 
the self-management at 12 months. Further researches are necessary to clarify this outcome. The 
researchers hypothesize the reduction of health coaching frequency at 3-month after leaving the 
hospital might the cause of the absence of result at 12 months. Healthcare practitioners may benefit 
from a patient-personalized self-management program to alleviate the symptom burden of COPD 
and decrease hospital readmission rates.  
Web-Based Videos Training to Improve Inhalation Technique 
COPD is a serious illness. People touched by COPD may experience aggravation of the 
disease that can be fatal or lead to hospital admission or emergency department visits. Inhalation 
therapy constitutes the main and preferred treatment for COPD (Windisch et al., 2018). Patients 
have to apply the proper inhaler technique for the medication to be effective. Numerous studies 
have demonstrated that COPD exacerbations continue to rise due to incorrect inhaler technique. 
REDUCING COPD EXACERBATION AMONG AFRICAN AMERICANS AFFECTED 
WITH COPD  
 16 
 
Researchers specify 90% of patients used improper inhaler technique in experimental studies 
(Maricoto et al., 2018). According to Maricoto et al. (2018), teaching inhaler technique may 
decrease the probability of exacerbations and mortality rates in COPD patients. The effect of 
inhaler training declines over time, which makes it important to continuously reevaluate inhaler 
technique (Maricoto et al., 2018). Teaching the proper technique for inhalation therapy may be 
done in direct contact with the patients or via web based. Windisch et al. (2018) have conducted a 
research to evaluate the relative effects of a web-based video training versus a typical individual 
training on decreasing inhalation mistakes in patients with severe COPD requiring hospitalization. 
The study was a randomized controlled trial conducted at the Department of Pneumology, 
Cologne Merheim Hospital, University of Witten/Herdecke, Germany, and it was approved by the 
ethics of the University of Witten/Herdecke and realized in accordance with the Declaration of 
Helsinki. All patients have given a written informed consent to participate in the study (Maricoto 
et al., 2018). 
Patients were recruited between December 2012 and June 2014. The inclusion criteria were 
patients with confirmed COPD by full body plethysmography, patients who meet the GOLD-
criteria for COPD, and those who use an inhaler prior to hospital admission. Patients were 
excluded if they had an acute respiratory failure as defined by a pH <7.35, a respiratory 
rate >23/min at rest, oxygen need of >3L/min. Also, patients with neurological, orthopedic or 
mental conditions that can alter inhaler treatment were excluded. Patients were aimlessly divided 
into two groups, one in which they received in-person training by a physician, and the other in 
which they had web-based video instructions.  
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Incorrect use of an inhaler was individually analyzed using the standardized checklists, 
which can be accessed at Checklists - Deutsche Atemwegsliga e.V. (English). It was anticipated 
that patients who commit two or more mistakes will inadequately perform the inhalation technique 
undoubtedly; therefore, all those will receive training on inhalation technique. 
A physician was responsible to conduct the individualized in-person teaching. Patients had 
received verbal and physical demonstration of the inhalation process; then, the patients had to 
practice correctly all steps with teach-back. After, the educator accentuates the steps that were 
mistakenly done. Finally, the patients ask questions.  
Patients in the web-based video training used a tablet device to access the training. Patients 
may watch the video as many times they estimated it necessary. The educator may assist the patient 
on how to operate the device to play the video; after that, the educator had no further interaction 
with the patients.   
After 24 hours, patient-related errors were analyzed with the same checklists. The same 
researchers have assessed both the pre-teaching and post-teaching errors to decrease the risks of 
researcher bias. Investigators conducted the appraisal were randomly assigned to the type of 
teaching intervention. Hence, each patient had two different researchers: one for the appraisal of 
patient-related inhalation mistakes (before and after teaching) and the other one for the teaching 
intervention. Despite training, more than 40% of the patients were unable to appropriately use the 
inhalers.  
Teaching outcomes and baseline assessment of handling errors were compared by 
computing the mean difference with 95% confidence interval and conducting a paired t-test 
independently for personal instruction and web-based video teaching.  
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The study established that both personal instruction and web-based training when applied 
to inhalation instruction can considerably enhance the inhalation practice. Nevertheless, non-
inferiority of web-based video teaching could not be statistically established due to the 
unpredictably great number of patients staying incapable to properly use an inhaler post-training 
in both groups. Therefore, additional studies are required to confirm the practicality of web-based 
video inhalation teaching for COPD patients. Overall, web-based videos are approximately as 
efficient as usual personal teaching attended by a physician in ameliorating the inhalation 
technique in COPD patients.  
Study Limitation and Strength 
The study had some limitations. First, the low number of participants in the web-based 
training make it difficult to demonstrate non-inferiority. Secondly, the timeframe of the web-based 
was not prospectively appraised to determine whether web-based instruction was a time saving 
approach. Yet, the fact that there was not any need for instructors in the video training kept the 
healthcare professionals accessible for other services. The time span between the two studies was 
24-hours, which is estimated to be short. The study encompassed only severe COPD patients that 
needed hospitalization. Additional studies are needed to appraise the results for moderate case of 
COPD. Finally, teach-to-goal approach was not applied, which may explain the high volume of 
failure in both groups.   
The strength of the study that it was the first study to compare personal instruction versus 
web-based video training. The study has demonstrated both methods are effective to improve 
inhalation technique. The researchers have pointed out that web-based video training was not 
intended to replace personal instruction; nonetheless, video training is beneficial for it does not 
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require the presence of a coach, and it is always available. Further studies are still needed to clarify 
the findings of the study.  
COPD: a disease burden  
Chronic obstructive pulmonary disease (COPD) is a lung ailment that harmfully affects 
individuals’ life with this condition (Criner & Han, 2018). COPD is a principal cause of morbidity, 
death, and expenses in the United States and globally (Criner & Han, 2018). It was anticipated that 
COPD will be the third principal cause of death in this year 2020 (Patel, Coutinho, Lunacsek, & 
Dalal, 2018). COPD represents the second main cause of functional and physical impairment 
(Criner & Han, 2018).  
COPD is described as continuous constriction of the airway linked to an advanced 
inflammatory reaction of the respiratory tract provoked by harmful elements or smoke (Robert et 
al., 2016). Cigarette smoking is the principal factor responsible for COPD development. In 
addition, numerous evidences have revealed that occupational exposure may provoke COPD in 
about 15% of cases. It is estimated that 29 million Americans live with COPD, yet only 13 million 
are aware of it (Criner & Han, 2018). COPD is a serious healthcare concern. Robert et al. (2016) 
report that COPD has affected over 210 million people globally in 2010. Furthermore, Sharifi et 
al. (2019) clarify that COPD is a worldwide health problem affecting about 300 million people 
and causing over 3 million deceases yearly. In the United Stated COPD prevalence is estimated to 
be 37% (Sharifi et al, 2019). 
COPD represents an enormous affliction that disturbs not only the affected individuals but 
also the clinicians and the community. Kiley & Gibbons (2017) explain many Americans are 
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unmindful of the danger represented by COPD despite the several works engendered by the 
healthcare authority, scholastic organization and other supporters. 
COPD Impact on Hospitalization Rates, Readmission and Healthcare Cost 
COPD exacerbations bring a heavy load on individuals affected by the disease. The acute 
respiratory distress of COPD is accompanied by a high risk of morbidity and mortality (Sadatsafavi 
et al., 2018). Researchers have been argued COPD exacerbations increase hospitalization rates and 
healthcare costs. As stated by Baker, Zou, and Su (2013) acute exacerbation of COPD is the most 
significant source of hospitalizations and readmissions in the United States.  
An average of 700,000 COPD patients get admitted to the hospital annually, and it was 
estimated at $32 billion in direct expenses in the year 2010 (Goto et al., 2017). In a study conducted 
in eight different states in the US from 2006 to 2012, researchers have found 1,161,207 hospital 
admissions for COPD; among them, 845,465 had a high probability for 30-day readmissions (Goto 
et al., 2017). Additionally, the study reveals that COPD 30-day readmission remains elevated due 
to patients’ comorbidities, unsatisfactory care and accessibility to health care (Goto et al., 2017). 
It is meant to explain decrease hospital admission and 30-day readmission is crucial to enhance 
healthcare quality and cut expenditure related hospitalizations. 
While COPD by itself constitutes a critical encumbrance on healthcare, it inflicts a more 
substantial impact of healthcare expenses when linked with other health-related morbidity and 
mortality.  Mannino et al., (2015) explain comorbidities generally determine the quality of health, 
health cost and disease evolution of patients with COPD. In a retrospective observational study, 
Mannino et al. (2015) have shown COPD associated with various comorbid conditions consumes 
an excessive amount of money and asset uses. Besides, COPD associated with comorbidities 
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increases the prevalence of ED visits that lead to hospitalizations (50.1% vs 9.5% with no 
comorbidities). The findings of the study correlate with other studies in terms of healthcare cost 
and impact of comorbidities on COPD-related hospitalizations albeit there is insufficient 
information concerning indirect expenses due to COPD and comorbidities (Mannino et al., 2015). 
Moreover, while it is important to treat other diseases associated with COPD, the treatment of 
COPD remains the same, and patients’ comorbidities should be managed as individuals are not 
affected by COPD (Mannino et al., 2015). The study concludes additional research is needed to 
comprehend the management of COPD and other comorbid conditions. It understood from this 
research, healthcare providers need to be alert about other diseases that can influence health care 
outcomes when caring for COPD patients.  
COPD Impact on Patients’ Welfare (Productivity, Disability) 
COPD patients experience mediocre life quality. It has been reported COPD patients are 
physically and emotionally affected. Patients’ perceptions and comportments about COPD and its 
effect on their welfare have been outstandingly overlooked (Jarab et al., 2018). Difficulty breathing 
is responsible for the lack of activity of patients with COPD. Jarab et al. (2018) argue shortness of 
breath causes COPD patients COPD to avoid or slow down on physical activities. Besides, 
individuals with severe COPD find it difficult to accomplish simple tasks, which makes them rely 
on family or caregivers (Jarab et al., 2018). Frailty associated with COPD makes affected patients 
isolated themselves and decreases their willingness to participate in social or leisure activities, 
which leads to anxiety and depression. As stated by Jarab et al. (2018), patients explain that their 
depression and anxiety are related to their inability to manage, and their panic is due to breathing 
difficulty. The physical and psychosocial effects of COPD on patients’ quality of life need to be 
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taken into consideration when caring for COPD patients since they may negatively impact 
treatment outcomes. 
COPD Self-Management Program 
COPD is a manageable and avertable disease, yet numerous patients continue to experience 
recurrent episodes of exacerbations which represent recurrent factors of hospital stays and death 
(Bourbeau et al., 2016). Management of COPD focuses on making the exact diagnosis, averting 
additional threats, monitoring symptoms and controlling complications (Make, 2003). COPD 
management should highlight ailment self-care to improve patients’ wellbeing. Healthcare 
clinicians need to develop a concerted self-management program to integrate patients into their 
health decision-making. Make (2003) emphasizes a cooperative self-management strategy 
identifies the patients’ responsibility in their health evaluations and the healthcare practitioners’ 
role as mentors and promoters of the patients’ health choices. Cannon et al. (2016) explain self-
management program aims to promote people’s modifications of comportment which improves 
their overall health with the main objective of enhancing both performance and quality of life.  
Various studies have been conducted on the effect of COPD self-management programs 
on individuals’ quality of life and health outcome; none of the studies has established a standard 
of actions to universalize. A self-management program needs to be specific to the individuals’ 
positive or negative attitudes, comorbidities, social status, age, and level of education (Benzo, 
Abascal-Bolado, & Dulohery, 2016). A study on self-management among Chinese patients with 
COPD led by Wang, Nygårdh, Zhao, and Mårtensson (2016) reveals that being active and 
financially independent and being young adults have a constructive impact on self-management. 
In addition, self-management interventions encompass COPD training, an exacerbation action 
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strategy, and physical activity information (Cannon et al., 2016). COPD self-management program 
has been proven to be effective to better individuals’ quality of life and welfare, yet it is important 
to highlight which parts of self-management programs are the most helpful at enhancing COPD 
patients' well-being (Cannon et al., 2016). Healthcare clinicians need to be aware of the impact of 
self-management interventions in improving COPD patients’ health outcomes to promote a well-
structured program in everyday patient care.  
Inhaler Use and COPD Patients 
Patients affected with COPD often benefit from the use of bronchodilators in the form of 
inhalers. Adequate use of an inhaler and patients’ treatment adherence have a critical impact on 
patients’ symptom relief. There are numerous types of therapies that can improve clinical 
outcomes for COPD patients; nonetheless, explaining the medical management of COPD is 
beyond the scope of this project. The Global Initiative for Chronic Obstructive Lung Disease 
(GOLD) report specifies inhaled short-acting bronchodilators (beta-2 agonist and/or muscarinic 
antagonist, and corticosteroid) is instrumental in the management of COPD exacerbations 
(Jardim & Nascimento, 2019). 
Inhalation treatment for COPD aims to transport the medication to the targeted location of 
action to diminish the risk of systemic absorption, to accomplish enhancement of symptoms and 
quality of life, and to decrease occurrence and gravity of exacerbations (Dougall, Bolt, Semchuk, 
& Winkel, 2016). Researchers have shown that current inhalers, besides their potential to manage 
COPD symptoms, are not accomplished the intended use due to the suboptimal inhaler technique 
(Usmani et al., 2018). Prescribers need to be aware of the numerous factors that can impede inhaler 
use to assist patients to receive a full benefit of the medication. Dougall, Bolt, Semchuk, and 
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Winkel (2016) argue to select the suitable devices for the specific patient those aspects of the 
inhaler need to be considered:  
• “Simplicity of setup  
• Ease of use  
• Cue that dose is taken  
• Need for dose counting  
• Locking mechanism  
• Dexterity required  
• Inspiratory capacity  
• Affordability”. 
Therewithal, patients’ age, level of education and associated comorbidities may impair 
their facility to properly use the inhaler (Dougall, Bolt, Semchuk, & Winkel, 2016). Training such 
as direct observational technique and individual matching inhaler are critical to enhancing the 
inhaler technique. Usmani (2019) argues healthcare practitioners’ role is instrumental in inhaler 
use, and he further explains the most efficient teaching strategy encompasses vocal coaching 
coupled to a physical exhibition. While arguing the role of healthcare practitioners and patients’ 
education to improve inhalation technique for COPD people, a study by Sanchis, Gich, and 
Pedersen (2016) reveals inappropriate inhaler use in patients with asthma and COPD has not 
improved over the past 4 decades despite patients’ education and technology improvement.   The 
study suggests creating tools that can evaluate inhaler- specific qualities of the procedure (Sanchis, 
Gich, & Pedersen, 2016).  
COPD Treatment Adherence 
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While COPD is a manageable disease, it remains a healthcare challenge due to acute 
aggravation of symptoms. COPD patients often endure poor disease outcome that results in 
hospital admission or emergency room visits. COPD is a chronic and progressive illness that 
necessitates affected individuals to adhere to prescribed medicines for treatment to be effective. 
Numerous researchers have found that improving COPD patient’s health outcomes is strictly 
attached to treatment adherence (Jardim & Nascimento, 2019). Rogliani et al. (2017) state COPD 
is an ongoing ailment that needs affected individuals to constantly take their prescribed medicines 
for a better result, yet treatment adherence is very small, which results in the poor outcome. Despite 
the negative impact of non-adherence on patients’ welfare, adherence to COPD treatment remains 
obstinately low. It is fundamental to identify and tackle barriers to treatment adherence to promote 
patients’ well-being.  
 Rogliani et al. (2017) stipulate adherence obstacles comprise various factors that can be 
associated with the treatment, to the affected individuals and the health care clinicians. A study by 
Bourbeau and Bartlett (2008) demonstrates the numerous causes that can alter patients’ treatment 
adherence. Factors related to patients are the patient’s health viewpoint, mental capabilities, self-
efficacy, age, and comorbid conditions (Bourbeau & Bartlett, 2008). Other factors influencing 
treatment adherence include types of medication, medication route of administration, patients’ 
social assistance, level of knowledge, and patient-providers bond (Bourbeau & Bartlett, 2008).  
Assessment of COPD Treatment Non-Adherence 
The understanding of the impact of treatment adherence on COPD outcomes had led 
researchers to investigate patients’ level of adherence to treatment. In an attempt to evaluate COPD 
adherence management, numerous tools have been created, and researchers have conducted 
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several studies. Scholars have developed numerous strategies to gauge patients’ non-adherence to 
prescribed medication. Rogliani et al. (2017) have mentioned different methods such as pharmacy 
refill approaches, electronic monitoring, and self-report measures; nevertheless, such methods 
carry substantial restrictions. Likewise, López-Campos, Quintana-Gallego, and Carrasco-
Hernández, (2019) have proposed other parameters to appraise inhaler’s treatment adherence, such 
as clinical monitoring, biochemical measurement, electronic monitoring, and general and specific 
questionnaires. While those strategies have provided clear insights in COPD clinical adherence, 
they cannot specify if the patients have effectively taken the medications (López-Campos, 
Quintana-Gallego & Carrasco-Hernández, 2019). It is understood, assessing treatment adherence 
is individual-specific, and healthcare providers need to take the opportunity to foster self-
management and treatment adherence through patients’ education and motivation at each visit.  
Interventions to Improve Quality of Life and Adherence in African American Community 
In spite it is well known the negative impact of non-adherence on COPD management, 
adherence to prescribed medication remains substantially minute. Scholars have determined that 
an average of 50% of medicines ordered for chronic illnesses are not taken appropriately, yet 
adherence rates for asthma and COPD are even lower with an approximation extending from 22% 
to 78% (George & Bender, 2019). It is fundamental to foster strategies that can enhance adherence 
among individuals affected by COPD. Communication between patients and the healthcare team 
is pivotal to boost patient adherence (Rogliani et al., 2017). Continuous dialogues between 
clinicians and patients to evaluate adherence, exacerbation prevention and inhaler technique at 
every encounter is critical to optimize and maintain patient adherence. George & Bender (2019) 
argue effective communication by clinicians assists to improve patient satisfaction and adherence, 
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which in turn enhances health quality and decreases health care costs. Also, patients’ participation 
in their healthcare decisions may play an important role in improving adherence. Mutual decision 
making between patients and health care providers in the choices of medications and treatment 
regimen based on patient preferences and values are instrumental to promote adherence; however, 
sharing-decision making needs to be guided by the well-versed available treatment taking into 
account probable risks and benefits (George & Bender, 2019). Improving patient-provider 
communication faces challenging hurdles, with time being the most important obstacle.  
Patient education is recognized as a significant element to stimulate adherence. As 
explained by Rogliani et al. (2017), clear comprehension of treatment may assist the patient to 
alter patient’s opinion about treatment burden, and subsequently to increase COPD treatment 
adherence and lessen hospital stay. Patient’s health knowledge is a pivotal factor to ponder when 
creating training and intervention strategies, so these strategies can be carried out at a suitable level 
to facilitate adherence to treatment (George & Bender, 2019). Applying a multidisciplinary team 
and using smart technologies may be useful to improve adherence. Community pharmacists can 
positively influence COPD treatment adherence and inhalation technique instruction; nonetheless, 
more information is needed to fully understand the role of community pharmacists (Rogliani et al., 
2017). Information technology applying text messages, electronic device reminders and phone 
calls may also influence adherence; however, patients might find it bothersome to incessantly 
receive numerous reminders (López-Campos, Quintana-Gallego & Carrasco-Hernández, 2019). 
Finally, medication expenditures, inhaler types and patient conditions need to be taking into 
consideration when reinforcing inhalation adherence (López-Campos, Quintana-Gallego & 
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Carrasco-Hernández, 2019). Healthcare clinicians should be mindful of adherence issues and take 
advantage to teach patients at every visit. 
Conclusion  
COPD is an important healthcare concern. It is the third leading cause of mortality in the 
US. Targeting COPD patients is critical to tackling the weight the disease put on people’s quality 
of life and healthcare costs. Researchers have demonstrated African Americans’ HRQL is more 
likely to be impacted by COPD exacerbations, and death related to COPD are higher among young 
African American adults. It is paramount to implement strategies that can improve the health and 
life quality of affected individuals, avert and manage exacerbations and complications, and 
decrease hospitalizations and mortalities. Treatment adherence and proper inhaler technique are 
promising interventions to assist African Americans in COPD self-management. Patient-provider 
communication, patient participation, personalized coaching, electronic reminders through phone 
calls and text messages are proven strategies that can be implemented to alleviate COPD burden 
for touched African American people. It is no doubt that a greater insight of exacerbations and 
plans intended to edify the prevention and management of COPD exacerbations in the African 
American people is imperative. Ejike (2019) stipulates that making healthcare affordable and 
creating ethnically insightful policies to overcome healthcare obstacles will support developing 
the welfare of African American patients with COPD.  
The Project  
Project Question  
Will an educational intervention improve COPD exacerbations in African American 
population after a 6-week self-management program that includes the proper use of an inhaler?  
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P: African Americans with COPD. 
I: Proper use of an inhaler 
C: Current practice. 
O: Reduction of COPD exacerbation and hospital admission. 
Definition of Terms 
Adherence 
Adherence has been defined as the “active, voluntary, and collaborative involvement of 
the patient in a mutually acceptable course of behavior to produce a therapeutic result”, (Ho, 
Bryson, & Rumsfeld, 2009). Patients’ willingness to take their medicines is crucial in health 
care. It is important for patients to agree with the practitioners that they understand the need to 
take their prescribed medicines and to be effectively involved in their health care for better 
outcome. As reported by Ho, Bryson, & Rumsfeld, 2009), “Drugs don’t work in patients who 
don’t take them”. 
COPD: Chronic obstructive pulmonary disease.  
COPD Exacerbation  
COPD exacerbation is described as an acute aggravation of dyspnea, cough and purulent 
sputum, not responding to the usual treatment (Criner & Han, 2018). With an acute exacerbation, 
the patient is often unable to breathe and carry out his or her daily activities. Patients who 
experience a COPD exacerbation often seek treatment in the emergency department or being 
admitted to the hospital. COPD exacerbation increases healthcare cost and hospitalization rates.   
Self-management 
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As defined by the Meriam-Webster dictionary, “Self-management is about “finding the 
self-control and mastery needed to take control of one's work”. In healthcare, self-management 
is an important concept that helps the patients to be actively and efficiently partake in their care 
to improve their quality of life. Lorig (1993) explains self-management is the process of 
mastering and applying the skills and knowledge necessary to live a satisfying life while 
enduring chronic ailments. The use of self-management in healthcare helps to improve patients’ 
quality of life and decrease healthcare cost (Lorig, 1993). 
Self-Efficacy 
Self-efficacy is the fact that one believes he is able and capable of achieving a particular 
behavior or a cognitive conduct (Lorig, 1993). Self-efficacy will motivate and empower the 
patients to self-manage their chronic conditions and enhance their quality of life.  
Introduction  
Managing COPD is very complex. The effect of COPD on affected people and family 
members is very burdensome. It is fundamental for primary care clinicians to tailor treatment for 
each patient. Primary care clinicians represent the principal point of contact for COPD patients, 
delivering approximately 80% of their health care (Sethi, 2018). With that information in mind, 
the project leader, with the assistance of a team composed of healthcare workers, non-clinical 
and administrative people, intends to conduct a COPD self-management project at a Clinical 
Center located in Miami.  
The Medical Center provides scheduled and urgently needed, culturally competent 
primary and specialty care services to residents of Liberty City in Miami. These services include 
but are not limited to physical examination, cholesterol screening, blood sugar screening and 
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control, blood pressure screening and control, spirometry testing, optometry service, and other 
specialty services via telemedicine. 
As the practice organization shapes the basis of all primary care settings, it is pivotal to 
highlight the operational structure of the institution. The Medical Center North West, Miami 
(NW office) is part of a large corporation. The corporate office is located in Homestead, Florida 
where the owner and Chief Executive Officer, and the administrative staff are situated. The NW 
office staff is composed of a medical director (MD), a center manager (CM) assisted with a 
system manager (named MCC: Medical Care Coordinators), healthcare providers, a registered 
nurse (RN), a registered pharmacy technician (RPT), medical assistants and front-desk 
clerks. Other employees at the practice are the dietary, the cosmetic, the environmental services 
and the drivers. Table-1.  
Table-1-Organizational Structure 
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The project aims at decreasing COPD exacerbation and hospital readmission rate among 
COPD patients in the NW office. The project’s main focus is to educate patients on proper 
inhaler technique. An assessment of the current practice relating to the management of COPD 
patients in the setting has guided the project leader to fathom the change needed for the project.  
Miami NW Office Practice Standard (The Immersion Site Current Practice) 
In the Miami NW office, there is no standard practice for COPD management. The 
providers have in their position a booklet named “Common Diseases”, where they can find 
information related to the most common pathologies found in primary care. With regard to 
COPD management, few data are available. It is recommended to use the GOLD guidelines to 
treat COPD patients. Care is provided according to the providers’ knowledge and understanding 
of the guidelines. One of the important policies of the clinic is the recommendation to have six 
encounters in a 30-day interval with all patients who were hospitalized for any causes. This 
protocol is interesting for it intends to prevent a 30-day hospital readmission, but there is no 
standard for follow-up with the patients during those visits. Most patients found it cumbersome 
and are not adherent to the treatment. It turns out to be ineffective to achieve that goal. In 
addition, most of the providers argued this protocol should be case based; for instance, they 
argue not all causes of hospitalization require six post-hospitalization appointments; for instance, 
a patient hospitalized for non-cardiac chest pain alleviated with regular pain medications does 
not need to be seen six times in 30-day after discharge.  
The clinical staff administrators have put in place specialty clinics to manage diseases 
such as diabetes and COPD. The idea is to lower A1c level and prevent COPD exacerbations and 
hospital admission. Either a medical director or a nurse practitioner is in charge of that respective 
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specialty clinic. This operation is done through telemedicine; a nurse or the provider who 
regularly sees the patient participates in that encounter. Once again, there is no practice standard. 
Finally, Miami NW office offers services such cardiology, nephrology and infectious diseases 
via telemedicine.  
It is current practice to conduct spirometry tests for all adult patient regardless of 
smoking status. There is no emphasis to make an early diagnosis of COPD. Most patients either 
already have the diagnosis of COPD or get diagnosed when they become symptomatic. Inhaler 
technique is seldom assessed. Patient’s education about the use of an inhaler is addressed in 
order to only differentiate the rescue inhaler from the maintenance inhaler. There is a deficiency 
in continuous reminder or education about inhaler technique. The table below highlights the 
main elements of strength, weakness, opportunities and weakness of the organization (Table-3). 
SWOT Analysis 
 
Strength
•Trained personals
•Spirometry use
•Telemedicine 
•Diagnostics & labs 
services
•Pharmacy
•Transportation
•Specialty clinic
Opportunities
•Specialists 
•Good insurance 
coverage 
Weakness
•No practice 
standard for COPD
•Limited drug 
availability in 
pharmacy
•Workload
•Time
•Employees’ 
satisfaction
Threats
•Patients’ level of 
literacy
•Medication costs
•Adherence to 
treatment
•Change in 
insurance plan
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GOLD Recommendations  
According to Global initiative for chronic Obstructive Lung Disease (GOLD, 2020) 
guidelines, patients who present symptoms of dyspnea, long-lasting cough or phlegm production, 
and/or a history of exposure to COPD risk factors should be diagnosed with COPD. The 
diagnosis needs to be confirmed with spirometry value. GOLD (2020) guidelines reveal “the 
presence of a post-bronchodilator FEV1/FVC < 0.70 confirms the presence of persistent airflow 
limitation and thus of COPD in patients with appropriate symptoms and significant exposures to 
noxious stimuli”. Spirometry alone should not be considered to make the diagnosis; patients’ risk 
factors and associated symptoms are additional elements to consider making the diagnosis of 
COPD (GOLD, 2020). Systematic spirometry screening is not recommended for the general 
population (GOLD, 2020). COPD case-finding is an important strategy to identify undiagnosed 
patients with COPD. GOLD (2020) promotes performing spirometry in symptomatic patients 
and/or patients with COPD related risk factors. Nevertheless, early detection of COPD has no 
effect on COPD treatment plan and outcome (GOLD, 2020). 
Methodology 
 
Project Goals and Outcomes 
COPD constitutes a healthcare challenge. COPD symptoms impact negatively people’ s 
quality of life, and affected individuals comprehend frequent exacerbations as a substantial 
chronic affliction preventing them from doing their daily activities (Miravitlles & Ribera, 2017). 
According to GOLD (2020), the principal objectives of treating COPD are to alleviate 
symptoms, slow disease development, avert and treat exacerbations, improve lung function, and 
decrease mortality. 
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The project aligns to the objectives of GOLD 2020 and aims to reduce COPD 
exacerbation frequency, which, in turn, will decrease hospital admission rates and improve the 
health-related quality of life (HRQL) of African Americans affected with COPD. The CAT and 
the Inhaler Device Assessment Tool (IDAT) were the main outcome variables to compute by 
comparing the pretest and posttest survey results. Alshabanat et al. (2017) argue patient 
education, disease management and follow-up can significantly reduce COPD exacerbation, 
hospital admissions and length of stay (LOS). 
COPD symptoms are linked with a clinically important deterioration in the quality of life. 
Improving the quality of life of COPD patients is a central point for healthcare management 
(Ahmed, Neyaz & Aslami, 2016). Researchers have applied numerous questionnaires to assess 
COPD symptoms and disease prognosis. The COPD Assessment Test (CAT) was used in this 
project for its simplicity and its short time to fill out. Other available tests are the Clinical COPD 
Questionnaire (CCQ), the Airways Questionnaire 20 (AQ20), the COPD Severity Score 
(COPDSS), and the St. George’s Respiratory Questionnaire (Miravitlles et al., 2015). The CAT is 
a dependable tool to assess individuals’ health status and has a scaling range of 0-40, with the 
higher number indicating worst health status (CAT, 2018)- Appendix B1-B2. The test should be 
administered every two to three months to identify symptoms variations and tendencies in CAT 
scale. A variation of 2 in the score indicates significant change in the health status and the quality 
of life (CAT, 2018). 
Description of the Program Structure 
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The project was implemented at the Miami NW office. Before implementation of the 
project, formal approval (Appendix F) was obtained from the office manager. Ten patients were 
recruited. Each patient had signed an informed consent letter to participate in the project.  
The office providers had helped to recruit COPD patients who are willing to participate in 
the program. The RPT was responsible to call patients on a monthly basis for medication refill 
and/or pick up. The project manager has used YouTube videos to illustrate the inhaler technique.  
Due to Covid-19, all interaction and teaching were done remotely using smart 
technologies. The providers assisting with the recruitment had contacted the participants via 
phone to introduce the project. Upon agreement, the participants had electronically received and 
signed the consent. The project leader had educated the patients in a one-to-one basis using 
virtual channel. Other means of communication were text messages and emails with the patients’ 
permission. No messages had carried patients’ personal data or identifiers. The project leader had 
sent the links of the video training and the survey through emails or text messages.  
Inhaler Technique Survey in the NW Office  
Proper inhaler technique being an important aspect in the management of COPD patients, 
it is fundamental to appraise the knowledge of the healthcare workers on how to adequately use 
an inhaler. In a brief survey, the project manager has assessed that the RN, the MAs, the RPT 
and the nurse practitioner are sufficiently competent in inhaler technique (Metered dose inhalers, 
MDIs). Competency was described as the aptitude to illustrate 100% of the steps appropriately, 
and any participants completing less than 100% was provided additional training until 
competency was established. The outcome showed the RN, the MA missed one step of a proper 
inhaler technique, and the RPT missed two steps. The nurse practitioner has adequately 
REDUCING COPD EXACERBATION AMONG AFRICAN AMERICANS AFFECTED 
WITH COPD  
 37 
 
completed all steps of the inhaler technique. This appraisal gives insight to initiate a training 
session for the RN, the MAs and the RPT before implementing the project.  
Participants’ risks and benefits 
The clinical providers had assisted in the recruitment of the patients. Participating in the 
project was voluntary, and there were no financial incentives to be a member of the project. All 
partakers had signed an informed consent. They had agreed to partake in all meetings and 
consent to be phoned at least once a week. Patients’ personal information or identity were not be 
collected or shared to any entities. There were no risks to physically or mentally harm the 
patients.  
Reliability and Validity of the Measuring Tools Applied in the Project 
The project manager has used the COPD Assessment Test (CAT) and the Self-Efficacy 
for Managing Chronic Disease 6-item Scale to shepherd the project. It is fundamental to inquire 
about the reliability and validity of any tools before they can be used in a scholarly project. The 
CAT is a self-administered questionnaire that assesses the patients’ welfare. The CAT has a scale 
from 0 to 40 (Table-2), with the higher number indicating worst health status.  A study by Karloh 
et al. (2016) concluded that the CAT is an important tool that meet the research criteria to 
classify as dependable and valid, and it is a responsive instrument to assess health-related quality 
of life of the COPD patients. 
Besides, the project leader has applied the Self-Efficacy to Manage Chronic Disease 
Scale (Appendix A) to assess the patients’ self-management capabilities to manage their COPD-
related symptoms. The Chronic Disease Self-Management Program (CDSMP) consists of a list 
of skills and knowledge that will explain the patients’ aptitudes to cope with their diseases (Lorig 
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et al., 2014). The scale encompasses 6 items ranked from one to 10, with one being not at all 
confident, and 10 being totally confident. To assess the practicality of the SEMCD, Lorig et al. 
(2014) direct a study to appraise the effectiveness of the program in patients with serious mental 
disorders. The authors determined CDSMP is a globally accessible resource that can empower 
the patients to take control over their chronic ailments (Lorig et al., 2014). 
Resources Required 
Upon project approval, the project manager has started the recruitment process with the 
assistance of the providers, and he has informed the administrative staff of the medical center 
each further step of the project. Resources that were available and applied during this project 
were the office manager, all clinical practitioners, one RN, two medical assistants and a RPT. 
The providers’ roles consisted to identify the COPD patients who can participate in the project, 
and with the project leader, explain the purpose of the recommendation and answer any enquiries 
the patients may have. The medical assistants helped with taking vital signs, doing spirometry 
test and other related aids deemed necessary per the office providers. The RN participated in 
educating the patients and reinforcing patients’ adherence to the inhaler. The RPT kept records 
of medication refill, called patients for reminders, and handed over pamphlets related to inhaler 
technique to the patients. Also included are other employees of the American Care Center, as 
well as select members of Florida International University, including faculty. COVID-19 
protocols were applied at every single step of the project. 
IRB Protocol Exemption  
The project instigator has submitted an Institutional Review Board (IRB) human protocol 
for review by the IRB committee. After a meticulous review of the IRB protocol, the Florida 
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International University (FIU) Office of Research Integrity has approved the project for 
implementation. See the IRB approval in Appendix G. 
Tools and Data Analysis 
 As previously stated, the project leader has used YouTube video to teach proper 
inhaler technique. The National Asthma Council (NAC) provides great quality and very 
informative videos on inhaler technique. The project manager has used the NAC video to 
provide the training. Providers and patients can access the videos following this link: 
https://www.nationalasthma.org.au/living-with-asthma/how-to-videos/how-to-use-mdi.  
It is crucial to appraise patients’ improvement in learning the proper use of an inhaler. 
The Inhaler Device Assessment Tool (IDAT) is an excellent tool that can assist healthcare 
providers to successfully assess patient’s understanding of the technique. The IDAT (Appendix 
D1-D4) provides information on all different steps to assist the patients. Being able to pinpoint 
patients’ knowledge and mistakes while performing the technique is paramount for teaching 
improvement. 
Patients’ adherence is an important factor for successful treatment. To understand the 
reasons for treatment failure, it is fundamental to start by ruling out non-adherence as a cause of 
treatment fiasco. The test of adherence to inhalers (TAI) is an excellent tool to gauge adherence. 
A study by Castillo et al. (2019) concludes the TAI is a “good method to measure a bad 
compliance.” The project manager has used the TAI test (Appendix C) to evaluate inhaler 
adherence. 
After application of the project, the project leader has employed quantitative data and 
graphs to assess and illustrate the project results. 
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Weekly meetings. Due to COVID-19, the project manager had kept in touch with the 
patients via phone calls, text messages, and virtual conferences when possible. A total of six-
weekly encounters had taken place. During each weekly and one-to-one meeting, participants 
were presented with a different topic while restating the previous week’s topics. All the 
participants were adhered to the plan.   
Week Topic Activities 
1 Participants’ 
expressing 
their views 
of COPD, 
self-efficacy, 
self-
management 
-Inhaler 
technique. 
Pre-assessment survey. Use of the following material from :  
https://www.aci.health.nsw.gov.au/__data/assets/pdf_file/0020/401483/
CATest.pdf 
https://www.selfmanagementresource.com/docs/pdfs/English_-_self-
efficacy_for_managing_chronic_disease_6-item.pdf  
https://www.nationalasthma.org.au/living-with-asthma/how-to-videos  
 
2 -Reinforce 
week one 
material 
-Teach back 
-Quit 
smoking  
-Questioning participants on week one material. 
Use of the following material from  
https://www.nationalasthma.org.au/living-with-asthma/how-to-videos  
for teaching and demonstration 
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3 Reinforce 
week 1, 2  
-Expressing 
feelings 
-Lifestyle 
change 
Participants Testimonials 
Use of the following material from  
https://www.nationalasthma.org.au/living-with-asthma/how-to-videos  
http://www.taitest.com/docs/Cuestionario_en.pdf  
 
4 Reinforce 
week 1, 2, 3 
-Compliance 
assessment   
-Teach back 
Participant testimonials 
Use of the following material from  
 https://www.nationalasthma.org.au/living-with-asthma/how-to-videos  
  
5 Reinforce 
week 1- 4 
- Inhaler 
technique. 
Inhaler technique demonstration:  
https://www.nationalasthma.org.au/living-with-asthma/how-to-videos  
https://use-inhalers.com/patients-handouts#Flyersn  
6 Reinforce 
week 1-6.  
-
Relationship 
with 
Provider. 
Encouragem
Post Assessment survey 
https://www.aci.health.nsw.gov.au/__data/assets/pdf_file/0020/401483/
CATest.pdf  
https://www.selfmanagementresource.com/docs/pdfs/English_-_self-
efficacy_for_managing_chronic_disease_6-item.pdf  
Small reception with light refreshment. (Cancelled due to COVID-19) 
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ents to 
participants 
Permission to use these teaching materials were entirely approved by each organization. 
Conceptual Underpinning and Theoretical Framework 
 
Bandura’s Self-Efficacy Theory 
Bandura's Self-Efficacy Theory represents the hallmark of this project.  It is assumed that 
anticipations of individual effectiveness help establish whether behavioral management will be 
started, how much determination will be consumed, and how much it will be endured when 
facing obstacle and unpleasant experiences (Bandura, 1977). According to Bandura (1977), 
“Persistence in activities that are subjectively threatening but in fact relatively safe produces, 
through experiences of mastery, further enhancement of self-efficacy”. Improving COPD self-
management is the focus for behavioral change for this project. Self-efficacy theories define how 
people sense, reason, encourage themselves and act. A strong awareness of efficacy improves 
individual achievements and personal welfare (Bandura, 1994). People who are confident in their 
aptitudes are more likely to stay resilient after facing obstacles. Bandura (1994) explain self-
assured people envision high expectations and remain devoted to them. They increase and 
sustain their determinations in case of disappointment and associate defeat with inadequate 
information and dexterities which they can acquire.  
To implement Bandura’s “expectations of self-efficacy’s” the project leader had involved 
the participants in interactive training about COPD self-management to improve their assurance 
in self-management. Bandura (1994) describes people’s beliefs in their efficacy into four 
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Enhanced Knowledge & Skills in 
COPD self-management 
Participant 
testimonials 
during meetings. 
principal foundations: “mastery experiences, vicarious experiences, verbal or social persuasion, 
and somatic and emotional states”. People tend to be motivated when they acquire the skills 
needed, when other people are previously succeeded in the same experience, when influenced or 
encouraged by others, and finally their feeling about the experience, which will define their 
senses of power or weakness. Figure 1 illustrates the model (see below). 
Figure 1. Model of Self-Efficacy Theory. 
 
 
Figure 2. Bandura’s Model of Self-Efficacy Theory modified in Terms of COPD. 
 
 
 
 
 
 
 
Inhaler Technique 
Monitoring 
Positive Encouragement 
during weekly meeting and 
calls 
Bandura Self-Efficacy 
Theory 
REDUCING COPD EXACERBATION AMONG AFRICAN AMERICANS AFFECTED 
WITH COPD  
 44 
 
Conceptual Framework 
COPD inflicts a heavy load on patients, families and healthcare providers and 
policymakers.  Strategy to manage COPD symptoms and exacerbations have been implemented, 
yet COPD continues to affect patient quality of life. It is anticipated that a self-management 
program can assist to alleviate this issue. Zhang et al (2013) have identified five domains of 
COPD self-management: “symptom management, daily life management, emotion management, 
information management, and self-efficacy”. The project aims to improve quality of life of 
COPD patients and to decrease hospital admission due to COPD exacerbations. Since self-
efficacy empowers patients to take control over their disease. The project aligns with the 
structure of self-efficacy to increase adherence to treatment, which, in turn, will decrease 
symptoms exacerbations. Asymptomatic patients will be more involved in daily activities and 
will frequent emergency department and/or hospital admission less often. 
Figure 3. 
 
 
 
Education
-Self-Efficacy
-Knowledge
Treatment 
Adherence
-Exercise 
Tolerance
-Symptoms 
-Hospital 
Admission
-Quality of Life 
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Results 
The project manager sought to accomplish the following goals: a decrease in COPD 
exacerbation frequency by teaching the proper use of an inhaler. Encouraging self-efficacy and 
promoting patient adherence are important factors to reach that goal.  
A total of ten patients were selected to conduct a pretest and post evaluation. All ten patients had 
completed the study. Parameters to evaluate were the CAT, Inhaler Device Assessment Tool 
(IDAT), the TAI, and the Self-Efficacy for Managing Chronic Disease 6-item Scale. The project 
outcomes are illustrated in the tables below.  
Patient Demographics 
In the recruited population, 70 % were females and 30% were males.  All patients were 
African Americans; 70% of them were over 65-year-old, and 30% below 65-year-old. They all 
have a confirmed COPD diagnosis, and they have at least 2 different inhalers: a rescue inhaler 
and a maintenance inhaler.  
 
Gender  Number n=10 Percentage 
Males 3 30 % 
Females 7 70 % 
Age Number n=10 Percentage 
Under 65 3 30% 
Over 65 7 70% 
Ethnicity  Number n=10 Percentage 
African 
Americans 
10 100% 
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Inhaler Device Assessment Tool (IDAT)  
For the inhaler assessment test, a checklist was utilized. Each participant underwent a 
pretest and a posttest. The mean in the pretest was 3.1 with a SD 1.43, and the mean was 4.6 in 
the posttest with a SD 0.48, which reflects a 1.5 improvement post teaching-Table 2-A. In 
addition, there is a clear difference in the number of critical errors in the pretest and the posttest. 
In the pretest, 10% of patients had completed the technique with no errors, 30% had committed 
one error, 40% had perpetrated 2 errors, 10% had carried out three mistakes, and 10% had 
missed 4 steps.  In the posttest, 70% of patients had successfully completed all steps of the 
inhaler technique, 20% had commit one mistake, and finally 10% had missed 2 steps-Table 2-B. 
No one has committed three or four errors in the posttest. The results support a clear 
amelioration in the inhaler technique.  
 
Inhaler Device Assessment Tool (IDAT) - Table 2. A 
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Critical Errors Observed in Patient Demonstrations- Table-2. B 
 
 
 
COPD Assessment Test (CAT)  
In the CAT, the pretest has a mean of 17.9 with a standard deviation (SD) of 7.25. The 
posttest has a mean of 9.9 and a SD of 6.21. The difference between the pretest and the posttest 
shows an improvement significance of 8 (Table 1-A & 1-B). Besides, the CAT is divided in five 
categories according to patients ‘symptoms: normal or good health, low, medium, high and very-
high. In the pretest, 10% of patients present with good health compared to 40% of patients in the 
posttest. The pretest and the posttest show similar rates in the low and medium groups 
respectively 10% and 50%. In the high classification, the pretest has a percentage of 30%, 
compared to nil in the posttest. No patients fall in the very-high classification of the CAT (Table 
1-C). 
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COPD Assessment Test (CAT)- Table-1. A 
 
 
 
 
COPD Assessment Test (CAT)- Table-1. B 
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CAT Classification- Table-1. C 
 
 
Test of Adherence to Inhaler (TAI) 
Inhaler adherence has a mean value of 46.4 with a SD of 14.23 in the pretest, and a mean 
value of 49.3 with a SD of 4.01 in the posttest, which reveals a difference of 2.9 in inhaler 
adherence improvement (Table 3-A). the Test of Adherence to Inhaler (TAI) allows to classify 
patients’ adherence as good, intermediate or poor. In the pretest, 40% of patients have a good 
adherence to the inhaler as opposed to 70% of patients in the posttest. In the intermediate 
adherence, the results show 30% and 20% in the pretest and posttest respectively. A percentage 
of 30% of participants have a poor adherence to the inhaler in the pretest compared to 10% in the 
posttest (Table 3-B). 
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Test of Inhaler Adherence- Table-3. A 
 
 
Types of Adherence-Table-3. B  
 
Self-Efficacy for Managing Chronic Disease 6-item Scale (SEMCD6S) 
In the SEMCD6S, the result indicates a difference in improvement of 3.4 with a mean 
value of 53 and a SD of 17.20 in the pretest, and a mean value of 56.4 with a SD of 11.56 in the 
posttest (Table 4). 
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Self-Efficacy-Table 4 
 
 
Discussion 
Limitation and Strength 
The project aims to decrease COPD exacerbation frequency among African Americans. 
This QI project provides data to back-up the interventions selected to reach the project goals. The 
project strength is its concordance with the findings of previous studies that reveals that proper 
inhaler technique can decrease symptoms of COPD patients and COPD exacerbation rates. A 
study by Ramadan et al. (2020) concluded that a proper inhaler technique is imperative for 
effective management of respiratory ailments. Other factors that reinforce the strength of the 
project are the validity of the tools used, such as COPD assessment test (CAT) and the Self-
Efficacy for Managing Chronic Disease 6-item Scale. However, an important limitation of the 
project is the sample size of 10 participants. A sample calculation was not included in the 
project. For that reason, the results study should be translated with caution. Sample size is crucial 
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for a project reliability since it can modify the outcome in either directions regarding medical 
decisions (Faber & Fonseca, 2014). Besides, the small sample size, the 6-week timeframe of the 
project constitutes a debatable factor for the study reliability. The actual pandemic COVID-19 
has affected the face-to-face training and the impact of Bandura’ self-efficacy might have on 
patients’ behavior. It is important to conduct further studies to understand how remote training, 
patient education and socio-economic status can impact the outcome of the project. Pothirat et al. 
(2015) argue inhaler technique in patients affected with COPD without direct coaching was 
generally disappointing, mainly in poorly educated patients.   
Implications for Advanced Practice Nursing 
Taking care of COPD patients may be challenging for healthcare providers. Patients’ 
education is an important parameter to take into account while planning care for sick patients. 
Nurse practitioners (NPs) have a crucial role to improve the quality of life of COPD patients. Bai 
et al. (2017) explain that smoking cessation exerts a positive impact in the natural history of 
COPD. NPs can assist patients in quitting smoking by providing suitable and consistent 
education on the beneficial effect of stopping smoking.  
The dyspnea associated with COPD may impair patients’ interaction and socialization, 
which may lead to depression, anxiety and loss of autonomy and self-sufficiency (George, 
2018). NPs may also help COPD patients to enhance their physical activity. NPs can 
educate patients with COPD about appropriate exercise and breathing technique that can 
increase their exercise tolerance and physical activities. Researchers have shown that regular 
physical activities are linked to a decrease in lung function deterioration and COPD risks among 
smokers (Bai et al., 2017).  
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COPD constitutes a financial burden on healthcare (Kirsch et al., 2019), and COPD 
exacerbation is the most frequent cause of hospitalization among COPD patients (Sogaard et al., 
2016). Studies have revealed that proper inhaler technique can decrease frequency of COPD 
exacerbation and improve patient’s life quality. NPs are well placed to provide COPD patients 
the training required to appropriately use the inhaler. NPs are important providers to decrease 
health care cost and hospital admission by promoting healthy behavior and self-efficacy skills 
among patients affected with COPD. NPs in their holistic approach to health care and guided by 
well-versed guidelines epitomize the core component to ease the burden of COPD over affected 
people.  
Dissemination and Sustainability  
A PowerPoint presentation about this educational process will be offered to faculty and 
peers of the medical centers, and in FNA conference. Additionally, the results of this project will 
be submitted to the Florida International University (FIU) DNP Program Director: Dr. T. 
Maltseva, to Dr. Garcia as the CEO of the medical center, to other DNP peers and nursing 
students, and to the Journal for Nurse Practitioners.  
The project results and implications have to be evaluated regularly to ensure and uphold 
high quality healthcare. Mortimer, Isherwood, Wilkinson, & Vaux (2018) emphasize a QI project 
can be sustained if the teams are trained to achieve the uppermost value enhancements. The 
project manager will coach the providers to understand the need for ongoing assessment of the 
inhaler technique among patients affected with COPD. In addition, the project leader will 
strengthen the importance of using the CAT and the IDAT tools by the providers to periodically 
assess and monitor patient outcome. The practitioners need to promote self-efficacy theory to 
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enhance patient self-care engagement. Finally, it is pivotal to introduce new approaches 
coupled with willingness and motivation toward change as ways to improve clinical 
practice. Silver et al. (2016) state to accomplish maintainable change, quality 
improvement initiatives must become the innovative method of functioning rather than 
some additional measures included into standard medical treatment.  
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Appendix A 
Self-Efficacy for Managing Chronic Disease 6-Item Scale 
 
 
 
 
 
 
 
 
 
 
 
 
1. How confident are you that you 
can keep the fatigue caused by 
your disease from interfering with 
the things you want to do? 
 
2. How confident are you that you can 
keep the physical discomfort or pain of 
your disease from interfering with the 
things you want to do? 
 
3. How confident are you that you can 
keep the emotional distress caused 
by your disease from interfering with 
the things you want to do? 
 
4. How confident are you that you can 
keep any other symptoms or health 
problems you have from interfering 
with the things you want to do? 
 
5. How confident are you that you 
can do the different tasks and 
activities needed to manage your 
health condition so as to reduce 
you need to see a doctor? 
 
6. How confident are you that you can 
do things other than just taking 
medication to reduce how much you 
illness affects your everyday life? 
 
 
 
 ______________________________  
not at all | | | | | | | | | | totally 
confident 1 2 3 4 5 6 7 8 9 10 confident 
 ______________________________  
not at all | | | | | | | | | | totally 
confident 1 2 3 4 5 6 7 8 9 10 confident 
 ______________________________  
not at all | | | | | | | | | | totally 
confident 1 2 3 4 5 6 7 8 9 10 confident 
 ______________________________  
not at all | | | | | | | | | | totally 
confident 1 2 3 4 5 6 7 8 9 10 confident 
 ______________________________  
not at all | | | | | | | | | | totally 
confident 1 2 3 4 5 6 7 8 9 10 confident 
 ______________________________  
not at all | | | | | | | | | | totally 
confident 1 2 3 4 5 6 7 8 9 10 confident 
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Impact Level of COPD on Health Status using the CAT Score. Appendix B1 
CAT Score Impact Level Possible management considerations 
5 Upper limit of normal in healthy 
non- smokers 
 
< 10 Low • Smoking cessation  
• Annual influenza vaccination  
• Reduce exposure to exacerbation 
risk factors  
• Therapy as warranted by further 
clinical assessment. 
10 – 20 Medium Patient has room for improvement – 
optimize management 
In addition to the guidance provided for 
patients with low impact CAT scores 
consider:  
• Reviewing maintenance therapy – 
is it optimal?  
• Referral for pulmonary 
rehabilitation  
• Ensuring best approaches to 
minimizing and managing 
exacerbations  
• Reviewing aggravating factors – is 
the patient still smoking? 
21 – 30 High Patient has significant room for 
improvement 
In addition to the guidance for patients with 
low and medium impact CAT scores 
consider:  
• Referral to specialist care (if you are a 
primary care physician)  
Also consider:  
• Additional pharmacological 
treatments  
• Referral for pulmonary 
rehabilitation  
• Ensuring best approaches to 
minimizing and managing 
exacerbations 
> 30 Very high Same as above (21-30) 
Table-2. Adapted from CAT (2018).  
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Appendix B2 
 
 
REDUCING COPD EXACERBATION AMONG AFRICAN AMERICANS AFFECTED 
WITH COPD  
 69 
 
Appendix C 
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Appendix D1 
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Appendix D2 
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Appendix D3 
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Appendix E 
Consent to Participate in A COPD Self-Management Program 
You are being asked to participate in a Doctorate in Nursing Project titled, “Reducing COPD 
exacerbations frequency among African Americans with COPD”   
You were chosen because your primary care providers at the American Care Center selected you. 
You are willingly participating in the project.    
The purpose of the project is to: 
1. Assist you to properly use an inhaler. 
2. Help you make healthier decisions in regard to smoking, exercise activities, and lifestyle. 
3. Increase your understanding of COPD and its complications 
4. Empower you as a person with COPD to better care for yourself 
5. Empower you with the knowledge required to enhance your breathing capability. 
During the program you are expected to: 
• Practice the inhaler technique. 
• Make healthy living habit, and include physical activities into your daily routine 
• Attend 6 weekly meetings for 30 minutes at the Center. To be included in the project, you 
must agree to attend at least 5 of the meetings. 
• Accept a once-a-week phone call to monitor your improvement while in the program. 
Risks/Deceptions of Being in this Program: There are no anticipatable (or expected) risks. 
There may be unknown risks.  
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Benefits of Being in the program: The benefits of participation are learning to manage your 
COPD better, learn how to avoid damaging complication of the disease, and understand steps to 
avert an exacerbation of COPD.  
Confidentiality: Your identity will not be revealed during or after the project. The records 
of this project will be held strictly confidential. We will not include any information in any 
report we may publish that would make it possible to identify you. Your identity will not be 
disclosed in any material that is published. 
Payments: You Will Not Receive Any Payment for Your Participation in This Project.  
The decision to participate in this project is exclusively up to you. You may decline to take part 
in the project at any time. Your decision will not result in any loss or benefits to which you are 
otherwise entitled.   
Questions and Concerns: You have the right to ask questions about this program and to have 
those questions answered during or after the program.   
Consent: Your autograph below specifies that you have decided to volunteer as a research 
participant for this quality improvement program, and that you have read and comprehended the 
aforesaid information. You will be given a signed and dated copy of this form to keep, along 
with any other printed documents considered necessary by the project manager.    
Participant Name (print): 
Participant Signature:  
Date: 
Project Leader Signature: 
Date: 
REDUCING COPD EXACERBATION AMONG AFRICAN AMERICANS AFFECTED 
WITH COPD  
 76 
 
Appendix F 
Medical Center Manager Approval Letter 
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Appendix G 
IRB Approval Letter 
 
 
 
